These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


276 related items for PubMed ID: 30753584

  • 21. Proton beam therapy reduces the incidence of acute haematological and gastrointestinal toxicities associated with craniospinal irradiation in pediatric brain tumors.
    Song S, Park HJ, Yoon JH, Kim DW, Park J, Shin D, Shin SH, Kang HJ, Kim SK, Phi JH, Kim JY.
    Acta Oncol; 2014 Sep; 53(9):1158-64. PubMed ID: 24913151
    [Abstract] [Full Text] [Related]

  • 22. Neurocognitive functioning in pediatric craniopharyngioma: performance before treatment with proton therapy.
    Fournier-Goodnight AS, Ashford JM, Merchant TE, Boop FA, Indelicato DJ, Wang L, Zhang H, Conklin HM.
    J Neurooncol; 2017 Aug; 134(1):97-105. PubMed ID: 28540667
    [Abstract] [Full Text] [Related]

  • 23. Neurocognitive and psychological functioning of pediatric brain tumor patients undergoing proton beam therapy for three different tumor types.
    Youn SH, Ha B, Lee EH, Park B, Yang SE, Yu ES, Kim JY.
    Pediatr Blood Cancer; 2022 Mar; 69(3):e29430. PubMed ID: 34766721
    [Abstract] [Full Text] [Related]

  • 24. Genetic susceptibility to cognitive decline following craniospinal irradiation for pediatric central nervous system tumors.
    Brown AL, Sok P, Raghubar KP, Lupo PJ, Richard MA, Morrison AC, Yang JJ, Stewart CF, Okcu MF, Chintagumpala MM, Gajjar A, Kahalley LS, Conklin H, Scheurer ME.
    Neuro Oncol; 2023 Sep 05; 25(9):1698-1708. PubMed ID: 37038335
    [Abstract] [Full Text] [Related]

  • 25. Could Rolandic spikes be a prognostic factor of the neurocognitive outcome of children with BECTS?
    Tristano I, Nicita F, Garone G, Ursitti F, Nardone C, Rocchi V, Guido CA, Spalice A.
    Epilepsy Behav; 2018 Sep 05; 86():157-162. PubMed ID: 30031676
    [Abstract] [Full Text] [Related]

  • 26. Monte Carlo-driven predictions of neurocognitive and hearing impairments following proton and photon radiotherapy for pediatric brain-tumor patients.
    Fortin D, Tsang D, Ng A, Laperriere N, Hodgson DC.
    J Neurooncol; 2017 Dec 05; 135(3):521-528. PubMed ID: 28825228
    [Abstract] [Full Text] [Related]

  • 27. A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma.
    Ho ESQ, Barrett SA, Mullaney LM.
    Acta Oncol; 2017 Aug 05; 56(8):1031-1042. PubMed ID: 28509599
    [Abstract] [Full Text] [Related]

  • 28. Intellectual changes after radiation for children with brain tumors: which brain structures are most important?
    Tsang DS, Kim L, Liu ZA, Janzen L, Khandwala M, Bouffet E, Laperriere N, Dama H, Keilty D, Craig T, Ramaswamy V, Hodgson DC, Mabbott D.
    Neuro Oncol; 2021 Mar 25; 23(3):487-497. PubMed ID: 33151327
    [Abstract] [Full Text] [Related]

  • 29. Predicting neurocognitive function in pediatric brain tumor early survivorship: The neurological predictor scale and the incremental validity of tumor size.
    McCurdy MD, Raghubar KP, Christopher K, Okcu MF, Wilde E, Desai N, Chu ZD, Gragert M, Stancel H, Warren EH, Whitehead WE, Grosshans D, Paulino AC, Chintagumpala M, Kahalley LS.
    Pediatr Blood Cancer; 2022 Sep 25; 69(9):e29803. PubMed ID: 35709014
    [Abstract] [Full Text] [Related]

  • 30. Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches.
    Moxon-Emre I, Dahl C, Ramaswamy V, Bartels U, Tabori U, Huang A, Cushing SL, Papaioannou V, Laperriere N, Bouffet E, Mabbott DJ.
    Cancer Med; 2021 Oct 25; 10(20):7111-7125. PubMed ID: 34480430
    [Abstract] [Full Text] [Related]

  • 31. Trajectories of psychosocial and cognitive functioning in pediatric patients with brain tumors treated with radiation therapy.
    Willard VW, Berlin KS, Conklin HM, Merchant TE.
    Neuro Oncol; 2019 May 06; 21(5):678-685. PubMed ID: 30624746
    [Abstract] [Full Text] [Related]

  • 32. Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma.
    Paulino AC, Ludmir EB, Grosshans DR, Su JM, McGovern SL, Okcu MF, McAleer MF, Baxter PA, Mahajan A, Chintagumpala MM.
    Cancer; 2021 Oct 15; 127(20):3865-3871. PubMed ID: 34254296
    [Abstract] [Full Text] [Related]

  • 33. Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy.
    Jalali R, Mallick I, Dutta D, Goswami S, Gupta T, Munshi A, Deshpande D, Sarin R.
    Int J Radiat Oncol Biol Phys; 2010 Jul 15; 77(4):974-9. PubMed ID: 19864079
    [Abstract] [Full Text] [Related]

  • 34. Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous system.
    McGovern SL, Okcu MF, Munsell MF, Kumbalasseriyil N, Grosshans DR, McAleer MF, Chintagumpala M, Khatua S, Mahajan A.
    Int J Radiat Oncol Biol Phys; 2014 Dec 01; 90(5):1143-52. PubMed ID: 25311260
    [Abstract] [Full Text] [Related]

  • 35. The comparison of acute toxicities associated with craniospinal irradiation between photon beam therapy and proton beam therapy in children with brain tumors.
    Uemura S, Demizu Y, Hasegawa D, Fujikawa T, Inoue S, Nishimura A, Tojyo R, Nakamura S, Kozaki A, Saito A, Kishimoto K, Ishida T, Mori T, Koyama J, Kawamura A, Akasaka Y, Yoshida M, Fukumitsu N, Soejima T, Kosaka Y.
    Cancer Med; 2022 Mar 01; 11(6):1502-1510. PubMed ID: 35137555
    [Abstract] [Full Text] [Related]

  • 36. Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation.
    Barney CL, Brown AP, Grosshans DR, McAleer MF, de Groot JF, Puduvalli V, Tucker SL, Crawford CN, Gilbert MR, Brown PD, Mahajan A.
    Neuro Oncol; 2014 Jan 01; 16(2):303-9. PubMed ID: 24311638
    [Abstract] [Full Text] [Related]

  • 37. Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient.
    Zhang R, Howell RM, Giebeler A, Taddei PJ, Mahajan A, Newhauser WD.
    Phys Med Biol; 2013 Feb 21; 58(4):807-23. PubMed ID: 23322160
    [Abstract] [Full Text] [Related]

  • 38. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
    Yock TI, Yeap BY, Ebb DH, Weyman E, Eaton BR, Sherry NA, Jones RM, MacDonald SM, Pulsifer MB, Lavally B, Abrams AN, Huang MS, Marcus KJ, Tarbell NJ.
    Lancet Oncol; 2016 Mar 21; 17(3):287-298. PubMed ID: 26830377
    [Abstract] [Full Text] [Related]

  • 39. Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma.
    Aldrich KD, Horne VE, Bielamowicz K, Sonabend RY, Scheurer ME, Paulino AC, Mahajan A, Chintagumpala M, Okcu MF, Brown AL.
    J Neurooncol; 2021 Oct 21; 155(1):93-100. PubMed ID: 34596831
    [Abstract] [Full Text] [Related]

  • 40. Cognitive predictors of social adjustment in pediatric brain tumor survivors treated with photon versus proton radiation therapy.
    Warren EAH, Raghubar KP, Cirino PT, Child AE, Lupo PJ, Grosshans DR, Paulino AC, Okcu MF, Minard CG, Ris MD, Mahajan A, Viana A, Chintagumpala M, Kahalley LS.
    Pediatr Blood Cancer; 2022 Jun 21; 69(6):e29645. PubMed ID: 35285129
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.